Articles tagged with Neurological Disorders
Researchers discovered that the brain suppresses the current action without using another mechanism to inhibit it, enabling seamless transitions between actions. This finding could lead to the development of biologically-inspired robotic systems and improve clinical treatments for Parkinson's patients.
A team of researchers from Goethe University and Kiel University has discovered a way to prevent the formation of harmful protein aggregates in cultured cells. The study found that linking TDP-43 with SUMO prevents its aggregation, suggesting a potential new approach for treating ALS and other neurodegenerative diseases.
A new study provides a method to estimate sample size required for microbiome studies based on effect sizes and analysis methods. For strong associations, around 500 participants were needed to achieve 80% statistical power, while weaker associations may require thousands of samples.
A recent study by the University of Zurich examined the connection between retinal nerve connections and schizophrenia. The researchers found that individuals with a higher genetic risk for schizophrenia tend to have thinner retinas, which can be detected using non-invasive retinal measurements.
Researchers highlight GOT2 as a compelling therapeutic target for treating pancreatic cancer, exploiting its role in regulating cellular redox balance and energy production pathways. Early candidates like amino oxyacetate show promise in disrupting GOT2 activity, leading to cellular senescence and loss of proliferative capacity.
The article provides a comprehensive overview of anaplastic thyroid cancer's molecular mechanisms, diagnostic approaches, and therapeutic strategies. Key findings include the significance of targeted therapies, such as BRAF and MEK inhibitors, and the potential of immunotherapy and novel agents to enhance treatment outcomes.
Citrullination, driven by peptidyl arginine deiminases (PADs), converts arginine to citrulline, altering protein structure and function. PAD2 and PAD4 play pivotal roles in epigenetic regulation, affecting transcriptional activity through histone modification and interaction with transcription factors.
Researchers found that adults under 50 with migraine headaches and certain heart defects are at increased risk of stroke. The study highlights the importance of assessing both traditional and nontraditional risk factors in younger people to prevent strokes.
Researchers at Tokyo University of Science have made breakthroughs in delivering gene-targeting compounds to the brain, using cholesterol-modified oligonucleotides that can penetrate the cerebral cortex beyond the blood vessels. This could lead to new treatments for diseases such as Alzheimer's and Parkinson's, as well as brain cancers.
Researchers at U-M and Stanford aim to create implantable brain computer interfaces to detect and interpret brain signals, enabling stroke victims to communicate more effectively. The devices will use tiny carbon-based electrodes to record signals from the brain's temporal region and transmit them wirelessly.
Researchers have found that people with cannabis use disorder have elevated dopamine levels in a brain region associated with psychosis. This could explain why frequent cannabis use increases the risk of hallucinations and delusions. The study's findings may help doctors educate patients about the potential risks of frequent cannabis u...
Dr. Romina Mizrahi's PET-based neuroimaging sheds light on brain workings, integrating genetics, environment and imaging to understand psychiatric illness as a complex biological puzzle. She advocates for precision psychiatry paradigm with customized treatments based on molecular profiles, and calls for diversity in academic leadership.
Researchers have discovered that the thalamus can update its own connections independently of the cortex, a finding relevant to children with neurodevelopmental disorders. This breakthrough suggests that modulating neurotransmitters in the thalamus could alter sensory processing and improve cognitive function.
Researchers at Temple University have discovered a new way to block the enzyme DLK, which plays a key role in neurodegenerative diseases. The breakthrough approach protects damaged neurons while preserving healthy neuron function.
A clinical study confirms that early treatment with fosdenopterin/rcPMP significantly reduces the risk of early death and promotes healthy brain development in infants with MoCD type A. The therapy restores the missing molybdenum cofactor, leading to improved developmental milestones.
A study of nearly 30,000 adults found that heart failure is associated with a significant decrease in cognition at diagnosis and rapid decline over time. Adults with heart failure reach the threshold for meaningful decline in global cognition nearly six years earlier than those without it.
A new study by McGill University researchers sheds light on the disruption of calcium transport in the brain's AMPA receptors, linking it to autism and intellectual disability. The findings could pave the way for treatments targeting these receptors, offering hope for patients with related neurological disorders.
A research group has uncovered a potential mechanism linking maternal inflammation to delayed neurodevelopment in infants. CD11c-positive microglia, crucial for myelination, play a key role in this process.
A recent study found that the protein tyrosine phosphatase delta (PTPRD) acts as a suppressor of the pro-inflammatory STAT3 pathway in liver cells, regulating lipid and glucose metabolism and protecting peroxisomal function. Reduced PTPRD expression was associated with signs of liver dysfunction and metabolic syndrome in humans.
Dr. Bing Ren, a renowned expert in genomics and epigenetics, joins the New York Genome Center as its new scientific director and CEO. His groundbreaking contributions will focus on translating genomic research into actionable insights for improving human health.
Scientists have long believed that cells respond to stress in a linear chain of events, but a new study reveals a more complex 'split-integrated stress response' that can be fine-tuned depending on the type and intensity of stress. This flexibility could lead to new targets for treating cancer and neurodegenerative diseases.
Research published in JAMA Network Open found that college graduates experienced faster cognitive decline after a stroke compared to those with less education. The study highlights the importance of identifying patients at high risk for post-stroke cognitive decline to target future interventions.
A new digital 'translator' for brain studies enables researchers to map the brain in a standardized way, facilitating discoveries and treatments for various disorders. The open-source software allows for the comparison of brain imaging data with widely used brain atlases, promoting commonalities across findings.
A study by Dr. LEE Seung-Hee reveals how the brain dynamically adjusts sensory input prioritization depending on movement, with vision taking priority for navigation. The posterior parietal cortex and secondary motor cortex play key roles in this process.
Researchers from Syracuse University found potential benefits of transcranial direct current stimulation (tDCS) on attention and fatigue in post-stroke patients, but results were mixed. Participants who received real tDCS showed decreased fatigue, while actual treatment did not improve attention tests.
A case study found Bartonella henselae, Babesia odocoilei, and Babesia divergens-like MO-1 DNA in brain tissue samples from a young child with seizures. The presence of these pathogens suggests their potential role in complex neurological illnesses.
Researchers found that selfish genes use self-assembly properties to harm cells, with aggregate size and distribution being key factors in toxicity. The study also reveals an evolutionary arms race between sabotage and salvation, where rapid evolution of 'selfish' genes can lead to their own destruction.
A review article reveals CD2AP's crucial role in amyloid metabolism, tau pathology, synaptic function, and neuroinflammation in Alzheimer's disease. CD2AP deficiency accelerates plaque formation, while its loss in neurons leads to reduced spine density and impaired synaptic plasticity.
A team of researchers found bacteria linked to the gut in the brains of mouse models implanted with microelectrodes, breaching the blood-brain barrier. The discovery highlights the need for permanent strategies to prevent bacterial invasion from implanted devices, which can contribute to inflammation and reduced device performance.
A recent study published in The Journal of the Alzheimer's Association found that lecanemab, a new Alzheimer's-modifying drug, was less effective in female patients compared to males. The Phase 3 clinical trial showed a significant benefit in males, but little to no benefit in females, with the cause of the difference still unknown.
The Open Brain Institute launches a groundbreaking platform to simulate and study digital brains, empowering researchers to explore brain complexity and diseases. With its virtual neuroscience laboratories, the OBI enables global collaboration and access to cutting-edge virtual labs.
A new study led by University College London researchers found that social disadvantages can accelerate ageing and increase disease risk. People with favourable socioeconomic conditions show fewer signs of biological ageing than peers of the same age.
Researchers at MIT have devised a simplified process to convert skin cells directly into neurons, bypassing the stem cell stage and achieving yields of over 10 neurons from a single skin cell. This approach could potentially be used to treat patients with spinal cord injuries or diseases that impair mobility.
A new model of brain computational analysis, called CHARM, reveals that the human brain can surpass machines in critical decision-making. The CHARM model applies quantum mechanics to analyze long-distance brain connections, enabling precise modeling of the brain's dynamics.
This new article highlights the critical role of tRNA-derived small RNAs in digestive tract diseases, positioning these molecules as potential biomarkers for diagnosis, prognosis, and targeted therapies. Recent findings emphasize the significance of tsRNAs in both tumor and non-tumor digestive diseases.
A new review article sheds light on the complex molecular mechanisms through which tumor-infiltrating immune cells regulate endometrial carcinoma progression. The study highlights key immune players, such as macrophages and regulatory T cells, that contribute to immune suppression, complicating treatment efforts.
The review article highlights the transformative potential of EZH2 inhibition, paving the way for targeted therapies aimed at disrupting tumor growth. EZH2 inhibitors have demonstrated significant clinical benefits in epithelioid sarcoma and follicular lymphoma, marking an important milestone in epigenetic-based cancer treatments.
Mechanosensitive adhesion G protein-coupled receptors (aGPCRs) play a crucial role in regulating biological processes and influencing cell behavior, development, and disease progression. Recent insights into their activation mechanisms reveal two primary models, highlighting the versatility of aGPCRs in adapting to mechanical cues.
Recent findings highlight the intricate interplay between non-coding RNAs and oxidative stress in cancer progression, shedding new light on mechanisms driving tumor development. Targeting these molecular interactions holds promise for therapies that could override drug resistance.
Researchers are enrolling volunteers for a four-year study that will use advanced imaging, genetics, exercise science, neuroscience, and remote monitoring to investigate age-related health decline. The goal is to help individuals and healthcare practitioners better prevent the impact of disease on older adults.
Dr. Guy Rouleau, a renowned geneticist and neurologist, has founded the world's first academic institution committed to open science principles. The Neuro institute aims to transform how brain disease research is conducted worldwide by promoting data sharing and collaboration.
A new study reveals that radiotherapy has opposite effects on glioblastoma multiforme (GBM) and low-grade gliomas (LGG), with GBM patients living longer after treatment. The study highlights the need for personalized treatment approaches based on genetic and molecular characteristics to improve survival outcomes.
Researchers at Virginia Tech's Fralin Biomedical Research Institute found that practicing episodic future thinking reduced impulsivity and enhanced brain connectivity in key regions. The study suggests that this approach may be a valuable early intervention therapy for substance use disorders.
The RGS12 protein plays a crucial role in regulating cellular signaling cascades and immune responses, influencing conditions such as osteoporosis and cancer. Its modulation may present opportunities for novel therapeutic strategies to address degenerative diseases and mental health disorders.
A nationwide study found that COVID-19 hospital patients experienced a higher rate of deaths from any cause and were more likely to be hospitalized for specific conditions, particularly neurological and respiratory problems. The study also identified increased risks of chronic health complications up to 30 months after discharge.
A new study reveals that schizophrenia's complexity is reflected in the individual brain structures of patients, with some experiencing perceptual disturbances and others cognitive impairments. The research suggests a precision medicine approach could tailor therapies to each patient's unique neurobiological profile.
Scientists found that parts of human chromosomes have evolved rapidly to enable complex brain development in humans. However, this acceleration may also lead to neurodevelopmental disorders like autism. The study used artificial neurons derived from human and chimpanzee cell lines.
La Jolla Institute scientists found that a protein in brain cells drives Parkinson's onset and may explain why the disease is more common in men. PINK1 appears to mark brain cells for immune cell attack, leading to inflammation and death.
The mTOR pathway is crucial in the progression of diabetic nephropathy and offers potential directions for effective treatment strategies. Excessive activation of mTOR contributes to kidney injury by inhibiting autophagy, increasing oxidative stress, and promoting inflammation.
Research identifies GATA6's crucial role in pancreatic ductal adenocarcinoma (PDA) progression and its potential as a biomarker and treatment target. Higher GATA6 expression correlates with better tumor differentiation, while low levels are linked to aggressive basal-like PDA.
The ubiquitin-proteasome system regulates tumor cell proliferation, immune evasion, and metastasis. The study identifies key enzymes and proteins involved in the process, highlighting potential therapeutic strategies for cancer treatment.
A study published in the Journal of Neurosurgery found that surgery can alleviate psychiatric distress and improve cognitive function in patients with Chiari Malformation type 1. Nearly 90% of patients showed improvements in cognitive function or psychiatric symptoms, with many reporting a significant reduction in brain fog.
Researchers at MIT's Picower Institute have discovered a new approach to treating fragile X syndrome by enhancing the activity of a specific component of 'NMDA' receptors. This strategy normalizes protein synthesis, neural activity and seizure susceptibility in hippocampus of fragile X lab mice, offering a promising therapeutic target.
A panel of experts identified key biomarkers for PND through a comprehensive literature review of 194 clinical studies. The study highlights the potential for these biomarkers to predict and diagnose PND, improving postoperative cognitive health in elderly patients.
Sylvester's Firefighter Cancer Initiative reduces cancer risk among firefighters and community members by addressing electric vehicle fires. A new gene-editing study aims to treat mitochondrial diseases, while a program connects patients with pathologists to improve understanding of complex results.
A recent MSU study highlights the challenges of diagnosing episodic disabilities like epilepsy, where symptoms fluctuate and can be unpredictable. The research found that 52% of participants experienced delayed diagnoses, while others faced quick confirmations within days of their first seizure.
A new telerehabilitation care service for stroke patients is being offered in Cameron County, Texas, as part of a randomized clinical trial. The program uses software delivered through a website to provide personalized rehabilitation regimens and community health worker home visits.
Researchers from Osaka University found that peristaltic pump action promotes amyloid nucleation in supersaturated fluids, including blood and cerebrospinal fluid. High shear stress caused by the pumping motion mechanically breaks supersaturation to induce amyloid formation.
A new study from the University of Texas at Arlington found that Americans aged 65 and older who experienced parental divorce as children were more likely to suffer a stroke compared to their peers. The study analyzed data from over 13,000 older Americans and found that about 14% had experienced parental divorce during childhood.
A comprehensive review published in Brain Medicine maps out the extensive influence of reproductive hormones on neurological health and disease. The study examines how sex hormones affect a broad spectrum of neurological conditions, including vascular disorders, movement disorders, epilepsy, multiple sclerosis, and Alzheimer's disease.